Contract Pharmacal

Executive Summary

Contract Pharmacal has been a leading contract development and manufacturing organization (CDMO) for over five decades, specializing in drug delivery solutions. Founded in 1971 and headquartered in Hauppauge, New York, the company has built a reputation for high-quality manufacturing and regulatory compliance. As a private entity, it serves a diverse client base ranging from emerging biotech to established pharmaceutical companies. The company's core capabilities include formulation development, scale-up, and commercial manufacturing of oral solids, liquids, and semi-solids. Its long-standing presence in the industry and continuous investment in state-of-the-art facilities position it as a reliable partner in the increasingly outsourced pharmaceutical supply chain. The CDMO market is benefiting from strong tailwinds as drug developers seek to reduce capital expenditure and accelerate time-to-market. Contract Pharmacal's expertise in complex drug delivery systems and its ability to handle both small and large batch sizes make it well-positioned to capture growing demand. However, as a private company, financial transparency is limited, and growth is dependent on securing new contracts and maintaining high operational standards. The company's commitment to quality and its track record of serving marquee clients underpin its competitive advantage, though industry consolidation and pricing pressure remain risks.

Upcoming Catalysts (preview)

• Q3 2026Announcement of major manufacturing agreement with a top-20 pharma company70% success
• Q2 2026Completion of facility expansion for high-potency oral solid dosage forms80% success
• Q4 2026Successful FDA inspection of new sterile manufacturing suite75% success